Verrica Pharmaceuticals's total assets for Q4 2025 were $47.13M, an increase of 15.25% from the previous quarter. VRCA total liabilities were $22.39M for the fiscal quarter, a -61.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.